<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJRad</journal-id><journal-title-group><journal-title>Open Journal of Radiology</journal-title></journal-title-group><issn pub-type="epub">2164-3024</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojrad.2018.82012</article-id><article-id pub-id-type="publisher-id">OJRad-85578</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Physics&amp;Mathematics</subject></subj-group></article-categories><title-group><article-title>
 
 
  Indications and the Outcome of the Mammography at Douala General Hospital (Cameroon)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mathurin</surname><given-names>Neossi Guena</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Natacha</surname><given-names>Doudou Ra&amp;iuml;ssa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Emmanuela</surname><given-names>Manka’a Wankie</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Frantz</surname><given-names>Cedric Nyatte</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Celestine</surname><given-names>Nguemgne</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wanko</surname><given-names>Woguep Laure Vanina</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Joseph</surname><given-names>Fotsin Gonsu</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Medical Imaging Center of Ngaoundere Regional Hospital, Ngaoundere, Cameroon</addr-line></aff><aff id="aff4"><addr-line>Radiology and Radiotherapy Department, Faculty of Medicine and Biomedical Sciences, The Universityof Yaounde I, Yaounde, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Department of Biomedical Sciences, Faculty of Science, The University of Ngaoundere, Ngaoundere, Cameroon</addr-line></aff><aff id="aff3"><addr-line>Medical Imaging Department of Douala General Hospital, Douala, Cameroon</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>mneossiguena@yahoo.fr(MNG)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>06</month><year>2018</year></pub-date><volume>08</volume><issue>02</issue><fpage>99</fpage><lpage>108</lpage><history><date date-type="received"><day>12,</day>	<month>May</month>	<year>2018</year></date><date date-type="rev-recd"><day>24,</day>	<month>June</month>	<year>2018</year>	</date><date date-type="accepted"><day>27,</day>	<month>June</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Recent reports indicate that the use of mammography in breast screening plays a major role in reducing breast cancer-related deaths. It helps to improve quality of care and patient information. However, in Cameroon, there are no organized general breast screening programs which give women the opportunity to regularly screen their breasts, except for the few who take their own initiative for breast screening. 
  Purpose: This study aimed to list indications and results of mammography and/or breast ultrasounds at Douala General Hospital in order to determine the proportion of routine mammographic screening. 
  Method: This descriptive cross-sectional study was carried out at Douala General Hospital using pre-established data sheets. The study recruited all patients who met the selection criteria and reported to the radiology and medical imaging department for breast screening using physical examinations, mammography and/or ultrasounds. 
  Results: The study recruited 372 patients, 96.8% of whom were between 40 to 50 years old. The reasons given for the medical consultation were systematic screening (33.01%); pain (27.18%) and lumps (25.24%). Breast examination by inspection was normal in 87.1% of women, and by palpation in 66.7%. Mammography revealed nodular opacities (18.3%), spiculated images (4.3%) and micro calcifications (3.2%), while ultrasound identified fibroadenomas (16.48%) and cysts (6.18%). Suspicious lesions (ACR 4 and 5) were discovered in 7.6% of cases by mammography and 8.51% of cases by ultrasound. The results indicated that there was no significant association between the use of clinical examination and mammography (p = 0.754). The use of clinical examination alone for breast screening may not be sufficient. 
  Conclusion: Our findings indicate that in Cemaroon, the routine screening mammography accounts for less than one-third (33.1%) of all indications. Benign lesions were most common, however 7.6% and 8.51% of suspicious malignant lesions were observed using mammography and ultrasound respectively.
 
</p></abstract><kwd-group><kwd>Mammography</kwd><kwd> Ultrasound</kwd><kwd> Breast Cancer Screening</kwd><kwd> Benign and Malignant Lesions</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Breast cancer is a major cause for concern for the medical staff as well as for the patients. It represents a little bit more than one-third of all cancers. It is reported to be the leading cause of cancer-related deaths among women with an estimated 11,500 deaths per year in France [<xref ref-type="bibr" rid="scirp.85578-ref1">1</xref>] .</p><p>In Cameroon, it is reported that breast cancer is the most common cancer (48.12%) among women [<xref ref-type="bibr" rid="scirp.85578-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.85578-ref3">3</xref>] . In low income countries, many of these cancer cases are detected at advanced stages due to lack of access to diagnostic equipment (medical imaging technologies) and routine medical consultations [<xref ref-type="bibr" rid="scirp.85578-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.85578-ref5">5</xref>] . Mammography, ultrasonography and Magnetic Resonance Imaging are the most common imaging modalities used for breast screening. Mammography is a low-dose-x-ray imaging modality used to create detailed images of the breast. It is the first line method for detecting breast cancer early when treatment is most effective. Indications for mammography can be put in two main groups. The first group is screening mammography which is performed on asymptomatic women and the second is diagnostic mammography mostly performed on symptomatic women [<xref ref-type="bibr" rid="scirp.85578-ref6">6</xref>] .</p><p>It is stated that early diagnosis improves prognosis. Breast screening using mammography is reported to reduce breast cancer-related deaths by 15% among women [<xref ref-type="bibr" rid="scirp.85578-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.85578-ref8">8</xref>] . Regular breast cancer screening leads to early detection of a great number of subclinical breast lesions that might require further investigations in order to specify their nature and more efficient treatment. There are two ways of organizing screening mammography. The first way is by communal screening which targets the general population. The second is by individual voluntary screening among women who are genetically susceptible or present high risks factors [<xref ref-type="bibr" rid="scirp.85578-ref9">9</xref>] . To the best of our knowledge, there has not been any regular organized communal breast screening program using mammography in Cameroon. However recently, public health authorities have given more importance to individual voluntary screening either by auto palpation or mammography or both. The aim of using mammography screening is to detect any abnormality in the breast by the analysis of images which could reveal precancerous lesions and small-size cancers. On the contrary, the use of palpation and other forms of physical examination in breasts screening, usually only detect advanced stage cancer and treatment is therefore delayed [<xref ref-type="bibr" rid="scirp.85578-ref9">9</xref>] . To the best of our knowledge no publication has been made in sub-Saharan African on the indications and results of mammography. We therefore conducted this study at the Douala General Hospital with a view to identify the reasons why women presented for mammography examination and the results obtained, with the end goal being to determine the place of individual routine screening mammography in this health facility.</p></sec><sec id="s2"><title>2. Material and Method</title><p>This cross-sectional descriptive study was carried out at Douala General Hospital for one year, from April 2016 to March 2017. Sampling was consecutive and exhaustive non-probabilistic. The study included all patients who came to the radiology and medical imaging department for breast imaging and freely consented to participate.</p><p>Each patient recruited for this study had to go through a clinical examination including medical history, inspection and palpation; followed by a mammogram with craniocaudal and medial-lateral oblique images. The use of ultrasound assessment of the breast was optional, depending on the age of the patient. Ultrasound is more useful for patients who are relatively young and/or have dense breasts. The images were read and described by the radiologist. The lesions were grouped according to the ACR’s BI-RADS classification, and the data collected on a pre-set data sheet. Patient confidentiality was paramount. Microsoft Office Excel 2013 and Sphinx version 5.1.0.6 were used for data analysis. Chi-square test was used with a precision threshold p = 0.05.</p></sec><sec id="s3"><title>3. Results</title><p>Three hundred and seventy-two (372) patients aged between 18 and 83 years old were enrolled in this study; 360 (96.80%) women and 12 (3.2%) men, with a sex ratio W/M of 30. The modal age group was 40 to 50 years old representing 33.33% (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The principal indications for mammography were : routine breast screening (33.01%), breast pain (27.18%), and breast lumps (25.24%) (<xref ref-type="table" rid="table1">Table 1</xref>). Clinical examination by inspection revealed that 87.1% of the study population had normal breast, 5.4% had breast lumps and 4.3% had breast scars (<xref ref-type="table" rid="table2">Table 2</xref>). Palpation revealed that 66.7% had normal breast and 26.9% had breast lumps (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Findings reported on mammograms included (<xref ref-type="table" rid="table4">Table 4</xref>): nodular opacities (18.3%), spiculated masses (4.3%), micro calcifications (3.2%) and normal breast (58.1%). Complementary ultrasound examination (<xref ref-type="table" rid="table5">Table 5</xref>) helped to identify and better characterise certain lesions such as fibroadenomas (32%) and cysts (12%). Suspected malignancies (ACR 4) accounted for 4.30% of mammography images and 2.13% on ultrasound images. Features strongly suggestive of cancer (ACR 5) were reported for 3.30% of mammograms and 6.38% of ultrasounds (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>The chi-square test shows that there was no statistically significant association between clinical findings and mammography (p = 0.754). However, there was a strong association between ACR classifications using mammographic and ultrasound (p = 0.01) (<xref ref-type="table" rid="table6">Table 6</xref>)</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of consultation motives</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >consultation motives</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >frequencies</th></tr></thead><tr><td align="center" valign="middle" >Routine Screening</td><td align="center" valign="middle" >136</td><td align="center" valign="middle" >33.01%</td></tr><tr><td align="center" valign="middle" >lumps</td><td align="center" valign="middle" >104</td><td align="center" valign="middle" >25.24%</td></tr><tr><td align="center" valign="middle" >Pain</td><td align="center" valign="middle" >112</td><td align="center" valign="middle" >27.18%</td></tr><tr><td align="center" valign="middle" >Tingling</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >6.80%</td></tr><tr><td align="center" valign="middle" >Nipple discharge</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >3.88%</td></tr><tr><td align="center" valign="middle" >Mastitis</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >1.94%</td></tr><tr><td align="center" valign="middle" >control</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >1.94%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >412</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Signs observed at the inspection</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Inspection</th><th align="center" valign="middle" >n.</th><th align="center" valign="middle" >Frequencies</th></tr></thead><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >324</td><td align="center" valign="middle" >87.1%</td></tr><tr><td align="center" valign="middle" >lumps</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >5.4%</td></tr><tr><td align="center" valign="middle" >scars</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >4.3%</td></tr><tr><td align="center" valign="middle" >mastitis</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >2.2%</td></tr><tr><td align="center" valign="middle" >Nipple discharge</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1.1%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >372</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Information revealed by palpation</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Palpation</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >Frequencies</th></tr></thead><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >248</td><td align="center" valign="middle" >66.7%</td></tr><tr><td align="center" valign="middle" >lumps</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >26.9%</td></tr><tr><td align="center" valign="middle" >Nipple discharge</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >5.4%</td></tr><tr><td align="center" valign="middle" >Pain</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1.1%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >372</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Lesions features on mammography</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Features</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >Frequencies</th></tr></thead><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >220</td><td align="center" valign="middle" >59.2%</td></tr><tr><td align="center" valign="middle" >Nodular opacities</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >18.3%</td></tr><tr><td align="center" valign="middle" >spiculated masses</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >4.3%</td></tr><tr><td align="center" valign="middle" >Micro calcifications</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >3.2%</td></tr><tr><td align="center" valign="middle" >Macrocalcifications</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >3.2%</td></tr><tr><td align="center" valign="middle" >Lymph nodes</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >3.2%</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >3.2%</td></tr><tr><td align="center" valign="middle" >No anwser*</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >5.4%</td></tr><tr><td align="center" valign="middle" >Total obs.</td><td align="center" valign="middle" >372</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><p>No answer*: patients who performed only breasts ultrasounds examination.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Lesions reported on breast ultrasound</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Lesions features</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >Frequencies</th></tr></thead><tr><td align="center" valign="middle" >Fibroadenomas</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >32%</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >32%</td></tr><tr><td align="center" valign="middle" >cysts</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >12%</td></tr><tr><td align="center" valign="middle" >Axillary lymph nodes</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4%</td></tr><tr><td align="center" valign="middle" >Dilated breast ducts</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4%</td></tr><tr><td align="center" valign="middle" >Abnormal intradermal structures</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4%</td></tr><tr><td align="center" valign="middle" >Gynecomastia</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2%</td></tr><tr><td align="center" valign="middle" >Other suspicious abnormalities</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >10%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Correlation between mammography and ultrasound findings and classification. There is a strong correlation between mammography and ultrasound (p = 0.01)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >ACR ultrasounds</th><th align="center" valign="middle"  rowspan="2"  >ACR 0</th><th align="center" valign="middle"  rowspan="2"  >ACR 1</th><th align="center" valign="middle"  rowspan="2"  >ACR 2</th><th align="center" valign="middle"  rowspan="2"  >ACR 3</th><th align="center" valign="middle"  rowspan="2"  >ACR 4</th><th align="center" valign="middle"  rowspan="2"  >ACR 5</th><th align="center" valign="middle"  rowspan="2"  >NA*</th><th align="center" valign="middle"  rowspan="2"  >TOTAL</th></tr></thead><tr><td align="center" valign="middle" >ACR Mammography</td></tr><tr><td align="center" valign="middle" >ACR 0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >24</td></tr><tr><td align="center" valign="middle" >ACR 1</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >124</td><td align="center" valign="middle" >200</td></tr><tr><td align="center" valign="middle" >ACR 2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >76</td></tr><tr><td align="center" valign="middle" >ACR 3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >24</td></tr><tr><td align="center" valign="middle" >ACR 4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >16</td></tr><tr><td align="center" valign="middle" >ACR 5</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >ACR 6</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >No Answer*</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >TOTAL</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >184</td><td align="center" valign="middle" >372</td></tr></tbody></table></table-wrap><p>NA*: Patients on whom only mammography was performed. No Answer*: Patients on whom only ultrasound was performed.</p></sec><sec id="s4"><title>4. Discussion</title><p>Recent reports indicate that the rate of breast cancer is increasing in sub-Saharan Africa [<xref ref-type="bibr" rid="scirp.85578-ref10">10</xref>] . In 2012, about 134,000 breast cancer cases were diagnosed with 63,000 breast cancer-related deaths in Africa. Sub-Sahara Africa alone recorded 94,000 breast cancer cases and 48,000 breast cancer-related deaths [<xref ref-type="bibr" rid="scirp.85578-ref11">11</xref>] . This is expected to double in the next 30 years probably due to lack of regular breast cancer screening and awareness among women. Breast cancer screening is one of the major public health concerns [<xref ref-type="bibr" rid="scirp.85578-ref5">5</xref>] . In Cameroon, there are no regular breast screening programs for women, perhaps due to lack of resources. Many women depend on self-breast examination or individual voluntary breast screening at the hospital [<xref ref-type="bibr" rid="scirp.85578-ref2">2</xref>] . It is sometimes based on a doctor’s request. This type of request is often limited to a small group of individuals and has a minimum effect on reducing breast cancer-related deaths when compared to organized free breast screening programs which give many more women the opportunity to undergo breast screening.</p><p>Lack of medical diagnostic equipment and qualified personnel in many poor resource countries are some of the major challenges to breast screening [<xref ref-type="bibr" rid="scirp.85578-ref4">4</xref>] . In Cameroun, mammography and ultrasound are the most commonly used diagnostic imaging modalities for breast cancer screening. At the early stage even without obvious symptoms, breast cancer can be detected by mammography. Breast cancer treatment is more efficient at these early stages than when the symptoms become apparent [<xref ref-type="bibr" rid="scirp.85578-ref10">10</xref>] . Randomised trials of breast cancer screening using mammography have been reported to reduce breast cancer-related deaths by at least 15% [<xref ref-type="bibr" rid="scirp.85578-ref8">8</xref>] . In the USA, there are well organized national breast screening programs for the public. This gives every woman and man the opportunity to regularly undergo breast screening annually or once every two years, using either mammography or more advanced methods for early detection of breast abnormalities [<xref ref-type="bibr" rid="scirp.85578-ref12">12</xref>] . It is also required by law that two independent radiologists meticulously read the images of the mammogram to attest the absence of cancer lesions [<xref ref-type="bibr" rid="scirp.85578-ref9">9</xref>] . A recent swedish study showed that in countries that offered routine screening mammography, there were 29% fewer deaths from breast cancer over a 16 year period among women who underwent screening, than those that did not [<xref ref-type="bibr" rid="scirp.85578-ref13">13</xref>] . In our study, we realized that 33.01% of women who presented for a mammography were asymptomatic and 67% were symptomatic with complaints like pain, nipple discharge or lumps. Although mammography is the most cost-effective approach for breast-cancer screening, our results, however, suggest that few women undergo breast screening mammography in Cameroun perhaps due to lack of organized free breast screening or awareness. Smith R.A. [<xref ref-type="bibr" rid="scirp.85578-ref13">13</xref>] , discussed the issue of the age at which women should begin breast screening, and what information can help women and their clinicians inform this decision. On school of thought holds that progress in therapy overlap the benefit of early detection and that the harms associated with screening outweigh the benefits. A second opinion discourages initiation of breast screening until the age of 50. The last school of thought supports initiation of screening at the age of 40 [<xref ref-type="bibr" rid="scirp.85578-ref13">13</xref>] . In this study, we realized the modal age subjects presenting for breast cancer screening was 40 - 60 years representing 66.33%. Similar findings were also reported by Belley and al, and Diakit&#233; N. [<xref ref-type="bibr" rid="scirp.85578-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.85578-ref15">15</xref>] . This is in line with the initiation of breast screening between the ages of 40 to 50 years. This finding also ties with recent recommendations by the American Cancer Society (ACS) in 2015 urging all women to start mammograms at age 45 or 40 [<xref ref-type="bibr" rid="scirp.85578-ref16">16</xref>] .</p><p>Breast screening by mammography is noted to be 77% to 95% sensitive and 94% to 97% specific in the detection and identification of breast lesions [<xref ref-type="bibr" rid="scirp.85578-ref17">17</xref>] . The use of mammography in this study contributed in the detection of different types of breast lesions such as nodular opacities (18.3%), spiculated images (4.3%) and micro calcifications (3.2%). We also classified 7.6% of these lesions which as suspicious of malignancy (ACR 4 or 5). The used of complementary ultrasound in this study helped detection and characterisation of lesions that were unnoticed on mammograms from subjects with dense breasts, as fibroadenomas (16.48%) and cysts (6.18%). Guegang and al in their study using ultrasound for the breast screening classified 16.5% of lesions as suspicious of malignancy [<xref ref-type="bibr" rid="scirp.85578-ref14">14</xref>] . However, in our study, we found much less (8.51%).</p><p>Although breast cancer in men is rare and accounts for only about 1% of all breast cancers [<xref ref-type="bibr" rid="scirp.85578-ref18">18</xref>] , 3.2% of our study population was male. Our findings, therefore suggest that well established organized free breast screening mammography programs in Cameroun may help in early diagnoses of patients with malignant lesions which are generally asymptomatic. It may also help patients with malignant lesions to start their treatments early, improve quality of care and possibly reduce breast-cancer related death.</p><p>It has been reported that mammography combined with clinical breast examination slightly improves sensitivity (77%) [<xref ref-type="bibr" rid="scirp.85578-ref17">17</xref>] . In this study, our results failed to show a significant correlation between the clinical examination and the mammography results (p = 75.4). This shows that the use of clinical examination alone is not sufficient for the detection of breast diseases such as small-size lesions or micro calcifications. Hence the recommendation for the combined clinical examination and mammography for a better outcome in breast screening. Ultrasound is mostly used to complement the evaluation of suspicious lesions detected on mammography and/or clinical examination. It is limited by a number of factors, notably the failure to detect micro calcifications and poor specificity (34%) [<xref ref-type="bibr" rid="scirp.85578-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.85578-ref20">20</xref>] . In this study, our results showed a significant association between ACR classifications on mammography and ultrasounds (p = 0.01). A couple of examinations show that the combined use of mammography and ultrasound seemed to be more reliable for detection and characterization of breast lesions among women over 45 years in Cameroon [<xref ref-type="bibr" rid="scirp.85578-ref21">21</xref>] .</p><p>As limitations: the study concerns a single hospital and cannot give the true level of breast cancer screening by mammography in Cameroon. The pathological anatomy was not performed to determine the true rate of cancer and benign lesions during screening.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Our study findings indicate that breast diseases in our context are more prevalent among relatively younger women. The most common reasons for performing mammography at the Douala General Hospital are routine screening (33.01%), pain (27.18%) and lumps (25.24%). Mammography revealed lesions suspicious of malignancy in 7.6% of cases and ultrasound revealed 8.51% of cases. The chi-squared independence test showed that there was no statistically significant association between clinical examination and mammography. Clinical examination thus proves inadequate for screening for breast pathology hence the importance of introducing mammography for breast cancer screening in our country.</p></sec><sec id="s6"><title>Acknowledgements</title><p>We thank the authorities of Douala General Hospital especially the staff of the Department of Radiology and Medical Imaging for their support during this study. We wish to thank Sylvanus Kampo for his contribution in editing this manuscript.</p></sec><sec id="s7"><title>Conflict of Interest</title><p>None.</p></sec><sec id="s8"><title>Cite this paper</title><p>Guena, M.N., Ra&#239;ssa, N.D., Wankie, E.M., Megnikengni, L.G., Nana, N.N., Inna, S., Nyatte, F.C., Nguemgne, C., Vanina, W.W.L. and Gonsu, J.F. (2018) Indications and the Outcome of the Mammography at Douala General Hospital (Cameroon). Open Journal of Radiology, 8, 99-108. https://doi.org/10.4236/ojrad.2018.82012</p></sec></body><back><ref-list><title>References</title><ref id="scirp.85578-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">National Cancer Institute (2011) The Cancer Situation in France in 2010. http://www.e-cancer.fr/</mixed-citation></ref><ref id="scirp.85578-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Enow-Orock, G., Mbu, R., Ngowe, N.M., Tabung, F.K., Mboudou, E., Ndom, P., et al. (2006) Gynaecological Cancer Profile in Yaoundé Population Cameroon. Clinics in Mother and Child Health, 3, 437-444.</mixed-citation></ref><ref id="scirp.85578-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Edzimbi, A.L. (2008) The Clinical and Histopathological Aspects of Breast Cancer in Cameroonian Women at HGOPY. Thesis of Medicine, FMSB; University de Yaoundé I.</mixed-citation></ref><ref id="scirp.85578-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Clegg-Lamptey, J.N. (2017) Epidemiology of Breast Cancer in Africa. OncologyPRO. http://oncologypro.esmo.org/content/download/102746/1814743/2017-ESMO-Africa-Epidemiology-of-Breast-Cancer-in-Africa-Joe-Nat+Clegg-Lamptey.pdf</mixed-citation></ref><ref id="scirp.85578-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Kantelhardt, E.J. and Frie, K.G. (2016) How Advanced Is Breast Cancer in Africa? The Lancet, 4. http://www.thelancet.com/lancetgh</mixed-citation></ref><ref id="scirp.85578-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Pascal, A., Baltzer, T., Panagiotis, K., Maria Adele, M. and Paola, C. (2017) New Diagnostic Tools for Breast Cancer. Memo, 10, 175-180. https://doi.org/10.1007/s12254-017-0341-5</mixed-citation></ref><ref id="scirp.85578-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Shapiro, S., Venet, W., Strax, P., Venet, L. and Roeser, R. (1982) Ten-to Fourteen Year Effect of Screening on Breast Cancer Mortality. Journal of the National Cancer Institute, 69, 349-355.</mixed-citation></ref><ref id="scirp.85578-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Nelson, H.D., Tyne, K., Naik, A., Bougatsos, C., Chan, B., Nygren, P. and Humphrey, L. (2009) Screening for Breast Cancer: Systematic Evidence Review Update for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 151, 727-737.</mixed-citation></ref><ref id="scirp.85578-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">High Authority of Health (2011) Screening for Breast Cancer in France: Identification of High-Risk Women and Screening Modalities. https://www.has-sante.fr/portail/jcms/c_1741170/fr/depistage-du-cancer-du-sein-en-france-identification-des-femmes-a-haut-risque-et-modalites-de-depistage</mixed-citation></ref><ref id="scirp.85578-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Abdulrahman Jnr., G.O. and Rahman, G.A. (2012) Epidemiology of Breast Cancer in Europe and Africa. Journal of Cancer Epidemiology. https://doi.org/10.1155/2012/915610</mixed-citation></ref><ref id="scirp.85578-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ferlay, J., Soerjomataram, I., Ervik, M., et al. International Agency for Research on Cancer. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARCCancerBase No. 11. Globocan.iarc.fr. Retrieved on December 16, 2016.</mixed-citation></ref><ref id="scirp.85578-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">DeSantis, C.E., Ma, J., Sauer, A.G., Newman, L.A. and Jemal, A. (2017) Breast Cancer Statistics, 2017, Racial Disparity in Mortality by State. CA: A Cancer Journal for Clinicians, 67, 439-448.</mixed-citation></ref><ref id="scirp.85578-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Smith, R.A., Kerlikowske, K., Miglioretti, D.L. and Kelager, M. (2012) Mammography Screening for Breast Cancer. The New England Journal of Medicine.</mixed-citation></ref><ref id="scirp.85578-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Belley Priso, E., Nguemgne, C., Obenchemti, E. and Mouné, A. (2010) Epidemiological and Clinical Profile of Breast Pathology at Douala General Hospital (Cameroon). Health Sciences and Disease, 11.</mixed-citation></ref><ref id="scirp.85578-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Nouhoum, D. (2011) Breast Cancer: Clinical and Therapeutic Aspects in the “A” Surgery Service of the G-Point CHU. African Journal of Cancer.</mixed-citation></ref><ref id="scirp.85578-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Thompson, D. (2015) Cancer Society: Mammograms Should Start at 45; Oct. 20. Health Day News. Retrieved on November 23, 2017.</mixed-citation></ref><ref id="scirp.85578-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Nelson, H.D., Tyne, K., Naik, A., Bougatsos, C., Chan, B., Nygren, P. and Humphrey, L. (2009) Screening for Breast Cancer: Systematic Evidence Review Update for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 151, 727-W242. https://doi.org/10.7326/0003-4819-151-10-200911170-00009</mixed-citation></ref><ref id="scirp.85578-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">League against Cancer. All Cancers: Breast Cancer.   https://www.ligue-cancer.net/localisation/sein</mixed-citation></ref><ref id="scirp.85578-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Erin Newton, V., Marie Catherine, L., Sara Grethlein, J., et al. (2017) Breast Cancer Screening. Medscape. https://emedicine.medscape.com/article/1945498-overview</mixed-citation></ref><ref id="scirp.85578-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Guegang, E., Sandjong, T.I., Tebeu, P.M., Temgoua, B.A., Sando, Z. and Moulion, J.R. (2012) Contribution of Ultrasound in Screening and Diagnosis of Breast Cancer: An Experiment from Yaoundé, Cameroon. Clinics in Mother and Child Health, 9.</mixed-citation></ref><ref id="scirp.85578-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Guegang, E., Magny, E.T., Wantou, L.G.S., Gonsu, J. and Sando, Z. (2009) Breast Cancer Screening. Ultrasound and Anatomopathological Mammography Correlation in Yaounde. Journal of Radiology, 90, 1494. https://doi.org/10.1016/S0221-0363(09)75848-2</mixed-citation></ref></ref-list></back></article>